相关实验视频

Updated: Jun 18, 2025

Modified Single-Loop Reconstruction for Pancreaticoduodenectomy

Modified Single-Loop Reconstruction for Pancreaticoduodenectomy

Published on: September 28, 2019

胰腺管切除术后的临床病理学评估内血管治疗的出血与内血管治疗

Tomoko Kugiyama¹, Masamichi Koganemaru¹, Akiko Sumi¹

¹Department of Radiology, Kurume University School of Medicine.

The Kurume medical journal

|August 4, 2024

概括

血管内治疗对胰腺切除术后出血 (PPH) 有希望. 胰腺脂肪透没有影响结果,但出血性休克和出血倾向与死亡率和并发症有关.

科学领域:

胃肠病学胃肠病学
干预性放射学干预性放射学
手术并发症手术并发症

背景情况:

胰腺切除术后出血 (PPH) 是胰腺手术后的一种严重并发症.
胰腺脂肪透或纤维化是胰腺的已知危险因素.
胰腺组织的组织病理学评估可以提供预后见解.

研究的目的:

评估PPH患者的干预程序的预后因素.
调查胰腺脂肪透/纤维化与PPH内血管治疗后的结果之间的关联.
评估PPH内血管治疗的有效性和安全性.

主要方法:

对接受内血管治疗的29名PPH患者的回顾性分析 (2001年9月 - 2020年3月).
单变量分析以确定胰腺组织病理特征,并发症和死亡率之间的关联.
评估内血管干预的技术和临床成功率.

主要成果:

内血管治疗的高技术 (97%) 和临床 (87%) 成功率.
住院死亡率为17% (5/29名患者).
没有发现胰腺囊与组织病理性脂肪透/纤维化之间存在关联.
出血性休克前治疗与住院死亡率有显著的相关性 (P=0.017).
出血倾向与治疗后并发症相关 (P=0.033).

结论:

内血管治疗似乎有效地管理PPH.
胰腺脂肪透/纤维化组织病理程度没有显著影响临床成功或预后.
出血性休克和出血倾向是影响PPH患者接受内血管治疗的临床结果的关键因素.

关键词:

临床病理学评估临床病理学评估血管内治疗血管内治疗胰腺脂肪透的情况胰腺纤维化是什么?胰腺抽的发生.胰腺外除术后出血胰腺外除术后出血

更多相关视频

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors

Published on: February 9, 2024

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis

Published on: March 15, 2024

相关概念视频

Esophageal Varices-II: Clinical Features and Management

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

Endoscopic Procedures V: ERCP

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...